We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genetix Grp | LSE:GTX | London | Ordinary Share | GB0001276863 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 84.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGTX RNS Number : 1443U Genetix Group PLC 19 June 2009 Genetix Group plc Presenting at Piper Jaffray European Conference New Milton, UK, 19 June 2009 - Genetix Group plc (AIM:GTX) ("Genetix" or the "Company"), the cell imaging and analysis group, today announces that its Chief Executive Officer, Charles de Rohan, will be presenting at the Piper Jaffray Fourth Annual European Conference in London on 24 June 2009. A webcast of the presentation will be available at www.genetix.com following the conference. =-Ends-- Genetix Group plc Charles de Rohan, Chief Executive Andrew Kellett, Finance Director Tel: +44 (0) 1425 624600 Financial Dynamics Jonathan Birt; Susan Quigley Tel: +44 (0) 20 7831 3113 Piper Jaffray Ltd James Steel; Tel: +44 (0) 20 3142 8700 The release will be available on the Company's website: www.genetix.com Notes to Editors About Genetix Group plc Headquartered in New Milton, UK, with offices in the UK, US, Germany and Japan, and quoted on the AIM (GTX: AIM), Genetix provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis in the life science and diagnostic markets. In life sciences, the company's systems set industry standards for accurate selection of microbial colonies, and for screening and selection of mammalian secretory cell lines. Other systems evaluate the response of cells to potential therapeutic agents and quantify tissue biomarkers. In diagnostics, Genetix holds a leading position in genetic testing with thousands of the company's platforms used in laboratories worldwide. Through its expertise in robotics, cell and molecular biology, image analysis and interpretation, supported by a strong IP portfolio, Genetix is committed to the continual development of innovative solutions. This information is provided by RNS The company news service from the London Stock Exchange END MSCILFSSRIITLIA
1 Year Genetix Grp Chart |
1 Month Genetix Grp Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions